Valuation: DiaSorin S.p.A.

Market Cap 3.67B 4.2B 3.39B 3.12B 5.89B 405B 6.02B 40.52B 15.94B 198B 15.79B 15.44B 683B P/E 2026 *
20.2x
P/E 2027 * 17.7x
Enterprise Value 4.35B 4.97B 4.01B 3.7B 6.97B 479B 7.12B 47.94B 18.86B 235B 18.68B 18.27B 808B EV / Sales 2026 *
3.55x
EV / Sales 2027 * 3.23x
Free-Float
37.17%
Yield 2026 *
1.88%
Yield 2027 * 1.96%
1 day-0.66%
1 week+0.73%
Current month+2.30%
1 month+7.37%
3 months+9.54%
6 months-7.10%
Current year+1.02%
1 week 68.38
Extreme 68.38
70.46
1 month 64.16
Extreme 64.16
71.78
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
92.32
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 2007-03-25
Director of Finance/CFO - 2024-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 2016-04-27
Director/Board Member 63 2007-03-25
Chairman 57 2022-04-28
Date Insider Type Main position Quantity % Market Cap.
3/24/26 Buy

Chief Executive Officer

9,211 0.0165%
1/28/26 Buy

Chief Executive Officer

7,500 0.0134%
1/8/26 Buy

Director

700 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-0.66%+0.73%-23.15%-24.82% 4.2B
+0.56%-2.61%+229.67%+311.59% 20.67B
+0.41%+4.58%-38.29%-21.77% 9.85B
+2.36%+1.85%+46.18%+23.10% 7B
-1.66%+2.36%+251.33%-25.86% 5.55B
+0.36%+3.63%-16.92%-28.57% 5.23B
+0.06%-2.94%-47.29% - 4.66B
+10.00%+34.69%+106.09%+132.05% 4.9B
-2.66%+4.71%-15.30%-40.67% 2.72B
-11.01%+2.37%-36.38%+212.50% 1.65B
Average -0.22%+5.90%+45.59%+59.73% 6.64B
Weighted average by Cap. +0.69%+3.74%+91.81%+111.31%

Financials

2026 *2027 *
Net sales 1.23B 1.4B 1.13B 1.04B 1.97B 135B 2.01B 13.52B 5.32B 66.16B 5.27B 5.15B 228B 1.3B 1.49B 1.2B 1.11B 2.09B 144B 2.14B 14.38B 5.66B 70.38B 5.6B 5.48B 242B
Net income 182M 209M 168M 155M 292M 20.09B 299M 2.01B 791M 9.84B 784M 766M 33.88B 205M 235M 189M 174M 329M 22.61B 336M 2.26B 890M 11.07B 882M 862M 38.12B
Net Debt 673M 770M 621M 572M 1.08B 74.15B 1.1B 7.42B 2.92B 36.32B 2.89B 2.83B 125B 542M 620M 500M 461M 869M 59.72B 888M 5.98B 2.35B 29.25B 2.33B 2.28B 101B
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2025, the group had 9 production sites located in Italy, the United States (4), Canada, Germany, the United Kingdom and Chine. Net sales are distributed geographically as follows: Italy (15.2%), Europe (24.9%), North America (51.8%), and other (8.1%).
Employees
3,242
Date Price Change Volume
26-07-17 €69.32 -0.66% 161,314
26-07-16 €69.78 +0.46% 131,069
26-07-15 €69.46 -0.32% 106,790
26-07-14 €69.68 +0.29% 185,659
26-07-13 €69.48 +0.96% 198,425
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
69.32EUR
Average target price
70.16EUR
Spread / Average Target
+1.22%

Quarterly revenue - Rate of surprise